Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status

Background: Nivolumab efficacy in patients with non-small-cell lung cancer (NSCLC) and performance status (PS) of 2-4 is unclear. We aimed to compare survival, treatment efficacy, and safety in patients with NSCLC with poor PS who received nivolumab plus best supportive care (BSC) with those in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsura, Hideyuki, Suga, Yukio, Araya, Tomoyuki, Kita, Toshiyuki, Yoneda, Taro, Tanaka, Nobuyoshi, Kawabata, Ayumi, Ishita, Sotoki, Mase, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584408/
https://www.ncbi.nlm.nih.gov/pubmed/31258716
http://dx.doi.org/10.7150/jca.31217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584408/
https://www.ncbi.nlm.nih.gov/pubmed/31258716
http://dx.doi.org/10.7150/jca.31217

Ejemplares similares